Table 1.
Species/Strain | DietREF | Histopathological changes in aortic valve | Hemodynamically significant stenosis? |
---|---|---|---|
Mice | |||
C57BL/6 | HF16 | Lipid deposition Modest calcification |
No |
ApoE−/− | Chow15 | Lipid deposition Calcification Monocyte/Inflammatory cell infiltration |
<2% |
HF/HC19, 33 | Lipid deposition Fibrosis19, 33 Calcification19, 33 Monocyte/Inflammatory cell infiltration19, 33 |
<2% | |
Ldlr−/− | HF/HC16, 223 | Lipid deposition Calcification Monocyte/Inflammatory cell infiltration |
No |
Ldlr−/−/apoB100/100 | Chow14 | Lipid deposition Calcification Monocyte/Inflammatory cell infiltration Myofibroblast activation |
Yes, ~30% of mice |
HF/HC12, 13 | Lipid deposition Calcification Fibrosis Monocyte/Inflammatory cell infiltration Myofibroblast activation |
Yes, >50% of mice | |
EGFRWa2/Wa2 | Chow11 | Fibrosis Calcification Inflammatory cell infiltration |
Yes, but background strain dependent |
eNOS−/− | Chow224 | Bicuspid aortic valves in ~40% of mice | Not known |
Notch1+/− | HF/HC125, 126 | Calcification | No |
Periostin−/− | Chow225 | Calcification Fibrosis |
Not known |
HF/HC226 | Reduced valve thickening and fibrosis | No | |
MGP−/− | Chow122 | Calcification | Not known |
Chm1−/− | Chow227 | Neoangiogenesis Lipid deposition Calcification |
Not known |
Rabbits | |||
New Zealand | HF/HC49, 79, 89, 209, 228–238 | Lipid deposition | <10% |
White | Calcification Inflammatory cell infiltration |
Mostly moderate sclerosis | |
Chow + | Fibrosis | <10% | |
HTN229 | Inflammation | ||
Watanabe | HF/HC49 | Lipid deposition Fibrosis Calcification Inflammatory cell infiltration |
No |
Pigs | |||
Yorkshire Landrace |
HF/HC83, 239 | Lipid deposition | No |